Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 62

1.

Cowpox virus protein CPXV012 eludes CTLs by blocking ATP binding to TAP.

Luteijn RD, Hoelen H, Kruse E, van Leeuwen WF, Grootens J, Horst D, Koorengevel M, Drijfhout JW, Kremmer E, Früh K, Neefjes JJ, Killian A, Lebbink RJ, Ressing ME, Wiertz EJ.

J Immunol. 2014 Aug 15;193(4):1578-89. doi: 10.4049/jimmunol.1400964. Epub 2014 Jul 14.

PMID:
25024387
[PubMed - in process]
2.

A high-coverage shRNA screen identifies TMEM129 as an E3 ligase involved in ER-associated protein degradation.

van de Weijer ML, Bassik MC, Luteijn RD, Voorburg CM, Lohuis MA, Kremmer E, Hoeben RC, LeProust EM, Chen S, Hoelen H, Ressing ME, Patena W, Weissman JS, McManus MT, Wiertz EJ, Lebbink RJ.

Nat Commun. 2014 May 8;5:3832. doi: 10.1038/ncomms4832.

PMID:
24807418
[PubMed - in process]
Free PMC Article
3.

Epstein-Barr virus large tegument protein BPLF1 contributes to innate immune evasion through interference with toll-like receptor signaling.

van Gent M, Braem SG, de Jong A, Delagic N, Peeters JG, Boer IG, Moynagh PN, Kremmer E, Wiertz EJ, Ovaa H, Griffin BD, Ressing ME.

PLoS Pathog. 2014 Feb 20;10(2):e1003960. doi: 10.1371/journal.ppat.1003960. eCollection 2014 Feb.

PMID:
24586164
[PubMed - in process]
Free PMC Article
4.

Survival of adults with acute lymphoblastic leukemia in Germany and the United States.

Pulte D, Jansen L, Gondos A, Katalinic A, Barnes B, Ressing M, Holleczek B, Eberle A, Brenner H; GEKID Cancer Survival Working Group.

PLoS One. 2014 Jan 27;9(1):e85554. doi: 10.1371/journal.pone.0085554. eCollection 2014.

PMID:
24475044
[PubMed - in process]
Free PMC Article
5.

Evaluation of viral interference with MHC class I-restricted antigen processing and presentation using a flow cytometry-based approach.

Horst D, Ressing ME, Mulder A, Wiertz EJ.

Methods Mol Biol. 2013;960:127-36. doi: 10.1007/978-1-62703-218-6_10.

PMID:
23329483
[PubMed - indexed for MEDLINE]
6.

EBV BILF1 evolved to downregulate cell surface display of a wide range of HLA class I molecules through their cytoplasmic tail.

Griffin BD, Gram AM, Mulder A, Van Leeuwen D, Claas FH, Wang F, Ressing ME, Wiertz E.

J Immunol. 2013 Feb 15;190(4):1672-84. doi: 10.4049/jimmunol.1102462. Epub 2013 Jan 11.

PMID:
23315076
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Hiding lipid presentation: viral interference with CD1d-restricted invariant natural killer T (iNKT) cell activation.

Horst D, Geerdink RJ, Gram AM, Stoppelenburg AJ, Ressing ME.

Viruses. 2012 Oct 23;4(10):2379-99. doi: 10.3390/v4102379. Review.

PMID:
23202469
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Viral interference with antigen presentation: trapping TAP.

Ressing ME, Luteijn RD, Horst D, Wiertz EJ.

Mol Immunol. 2013 Sep;55(2):139-42. doi: 10.1016/j.molimm.2012.10.009. Epub 2012 Nov 8. Review.

PMID:
23141382
[PubMed - indexed for MEDLINE]
9.

Inflammasomes and viruses: cellular defence versus viral offence.

Gram AM, Frenkel J, Ressing ME.

J Gen Virol. 2012 Oct;93(Pt 10):2063-75. doi: 10.1099/vir.0.042978-0. Epub 2012 Jun 27. Review.

PMID:
22739062
[PubMed - indexed for MEDLINE]
Free Article
10.

The "Bridge" in the Epstein-Barr virus alkaline exonuclease protein BGLF5 contributes to shutoff activity during productive infection.

Horst D, Burmeister WP, Boer IG, van Leeuwen D, Buisson M, Gorbalenya AE, Wiertz EJ, Ressing ME.

J Virol. 2012 Sep;86(17):9175-87. doi: 10.1128/JVI.00309-12. Epub 2012 Jun 13.

PMID:
22696660
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

CD200 receptor controls sex-specific TLR7 responses to viral infection.

Karnam G, Rygiel TP, Raaben M, Grinwis GC, Coenjaerts FE, Ressing ME, Rottier PJ, de Haan CA, Meyaard L.

PLoS Pathog. 2012;8(5):e1002710. doi: 10.1371/journal.ppat.1002710. Epub 2012 May 17.

PMID:
22615569
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Survival of endometrial cancer patients in Germany in the early 21st century: a period analysis by age, histology, and stage.

Chen T, Jansen L, Gondos A, Ressing M, Holleczek B, Katalinic A, Brenner H; GEKID Cancer Survival Working Group.

BMC Cancer. 2012 Mar 30;12:128. doi: 10.1186/1471-2407-12-128.

PMID:
22459016
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Epstein-Barr virus isolates retain their capacity to evade T cell immunity through BNLF2a despite extensive sequence variation.

Horst D, Burrows SR, Gatherer D, van Wilgenburg B, Bell MJ, Boer IG, Ressing ME, Wiertz EJ.

J Virol. 2012 Jan;86(1):572-7. doi: 10.1128/JVI.05151-11. Epub 2011 Oct 19.

PMID:
22013037
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Structural and functional analysis of the TAP-inhibiting UL49.5 proteins of varicelloviruses.

Verweij MC, Lipińska AD, Koppers-Lalic D, Quinten E, Funke J, van Leeuwen HC, Bieńkowska-Szewczyk K, Koch J, Ressing ME, Wiertz EJ.

Mol Immunol. 2011 Sep;48(15-16):2038-51. doi: 10.1016/j.molimm.2011.06.438. Epub 2011 Jul 20.

PMID:
21764135
[PubMed - indexed for MEDLINE]
15.

Exploiting human herpesvirus immune evasion for therapeutic gain: potential and pitfalls.

Horst D, Ressing ME, Wiertz EJ.

Immunol Cell Biol. 2011 Mar;89(3):359-66. doi: 10.1038/icb.2010.129. Epub 2011 Feb 8. Review.

PMID:
21301483
[PubMed - indexed for MEDLINE]
16.

EBV protein BNLF2a exploits host tail-anchored protein integration machinery to inhibit TAP.

Horst D, Favaloro V, Vilardi F, van Leeuwen HC, Garstka MA, Hislop AD, Rabu C, Kremmer E, Rickinson AB, High S, Dobberstein B, Ressing ME, Wiertz EJ.

J Immunol. 2011 Mar 15;186(6):3594-605. doi: 10.4049/jimmunol.1002656. Epub 2011 Feb 4.

PMID:
21296983
[PubMed - indexed for MEDLINE]
Free Article
17.

Inhibition of mouse TAP by immune evasion molecules encoded by non-murine herpesviruses.

Verweij MC, Ressing ME, Knetsch W, Quinten E, Halenius A, van Bel N, Hengel H, Drijfhout JW, van Hall T, Wiertz EJ.

Mol Immunol. 2011 Mar;48(6-7):835-45. doi: 10.1016/j.molimm.2010.12.008. Epub 2011 Feb 2.

PMID:
21292324
[PubMed - indexed for MEDLINE]
Free Article
18.

EBV lytic-phase protein BGLF5 contributes to TLR9 downregulation during productive infection.

van Gent M, Griffin BD, Berkhoff EG, van Leeuwen D, Boer IG, Buisson M, Hartgers FC, Burmeister WP, Wiertz EJ, Ressing ME.

J Immunol. 2011 Feb 1;186(3):1694-702. doi: 10.4049/jimmunol.0903120. Epub 2010 Dec 29.

PMID:
21191071
[PubMed - indexed for MEDLINE]
Free Article
19.

The capacity of UL49.5 proteins to inhibit TAP is widely distributed among members of the genus Varicellovirus.

Verweij MC, Lipinska AD, Koppers-Lalic D, van Leeuwen WF, Cohen JI, Kinchington PR, Messaoudi I, Bienkowska-Szewczyk K, Ressing ME, Rijsewijk FA, Wiertz EJ.

J Virol. 2011 Mar;85(5):2351-63. doi: 10.1128/JVI.01621-10. Epub 2010 Dec 15.

PMID:
21159875
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Viral evasion of T cell immunity: ancient mechanisms offering new applications.

Horst D, Verweij MC, Davison AJ, Ressing ME, Wiertz EJ.

Curr Opin Immunol. 2011 Feb;23(1):96-103. doi: 10.1016/j.coi.2010.11.005. Epub 2010 Dec 9. Review.

PMID:
21146386
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk